Earnings call NEXGEL posts record revenue in Q3 2024 amid growth initiatives

STAA Stock  USD 24.60  0.37  1.48%   
About 63% of all STAAR Surgical's investors are looking to take a long position. The analysis of overall sentiment of trading STAAR Surgical stock suggests that some investors are interested at this time. The current market sentiment, together with STAAR Surgical's historical and current headlines, can help investors time the market. In addition, many technical investors use STAAR Surgical stock news signals to limit their universe of possible portfolio assets.
  
Earnings call NEXGEL posts record revenue in Q3 2024 amid growth initiatives

Read at investing.com
Investing News at Macroaxis
  

STAAR Surgical Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards STAAR Surgical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

STAAR Surgical Fundamental Analysis

We analyze STAAR Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STAAR Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STAAR Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

STAAR Surgical is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

STAAR Surgical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with STAAR Surgical stock to make a market-neutral strategy. Peer analysis of STAAR Surgical could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics with similar companies.

Peers

STAAR Surgical Related Equities

ANGOAngioDynamics   3.68   
0%
100.0%
MBOTMicrobot Medical   3.09   
0%
83.0%
HAEHaemonetics   1.89   
0%
51.0%
NVSTEnvista Holdings   1.79   
0%
48.0%
MMSIMerit Medical   0.37   
0%
10.0%
HOLXHologic   0.06   
0%
1.0%
WSTWest Pharmaceutical   0.00   
0%
0%
RGENRepligen   0.00   
0%
0%
BDXBecton Dickinson   0.00   
0%
0%
RMDResMed   0.00   
0%
0%
COOCooper Companies,   0.22   
5.0%
0%
ATRAptarGroup   0.23   
6.0%
0%
ICUIICU Medical   0.33   
8.0%
0%

Complementary Tools for STAAR Stock analysis

When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital